2016
DOI: 10.4291/wjgp.v7.i4.300
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Helicobacter pylorieffect of CaG-NANA, a new sialic acid derivative

Abstract: AIMTo investigate the bactericidal effects of calcium chelated N-acetylneuraminic acid-glycomacropeptide (CaG-NANA) against Helicobacter pylori (H. pylori).METHODSFor manufacture of CaG-NANA, calcium (Ca) was combined with glycomacropeptide (GMP) by chelating, and N-acetylneuraminic acid (NANA) was produced with Ca-GMP substrate by an enzymatic method. The final concentration of each component was 5% Ca, 7% NANA, 85% GMP, and 3% water. For in vitro study, various concentrations of CaG-NANA were investigated un… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 21 publications
1
5
0
Order By: Relevance
“…Several lines of evidence point to a central role for bacteria of the Helicobacter genus in our data. A greater abundance of Helicobacter in ST6GAL1-deficient animals is consistent with a number of previous reports demonstrating that soluble sialic acid preparations have direct antibacterial properties towards Helicobacter species both in vitro and in vivo [91][92][93][94] . Although a physiological role for milk-derived sialic acid in protecting the neonate from Helicobacter colonization is plausible, human studies in multiple populations have failed to demonstrate any association between breastfeeding and Helicobacter colonization [131][132][133][134] .…”
Section: Subsequent Work Indicated That Fucosylation Of Enterocytes Psupporting
confidence: 91%
See 1 more Smart Citation
“…Several lines of evidence point to a central role for bacteria of the Helicobacter genus in our data. A greater abundance of Helicobacter in ST6GAL1-deficient animals is consistent with a number of previous reports demonstrating that soluble sialic acid preparations have direct antibacterial properties towards Helicobacter species both in vitro and in vivo [91][92][93][94] . Although a physiological role for milk-derived sialic acid in protecting the neonate from Helicobacter colonization is plausible, human studies in multiple populations have failed to demonstrate any association between breastfeeding and Helicobacter colonization [131][132][133][134] .…”
Section: Subsequent Work Indicated That Fucosylation Of Enterocytes Psupporting
confidence: 91%
“…In contrast, several Proteobacteria genera were expanded in ST6GAL1-deficient animals, including Helicobacter and Bilophila OTUs (Fig 3e). Helicobacter species, which are wellstudied pathogens in both animals and humans, have been shown to be inhibited by free sialic acid [91][92][93][94] . The bile-metabolizing genus Bilophila, which expands in response to dietary fat intake, was recently identified as a pathobiont, capable of promoting colitis 95,96 .…”
Section: St6gal1 Patterns the Postnatal Gut Microbiomementioning
confidence: 99%
“…properties both in vitro and in vivo [101][102][103][104][105][106] . Bile-metabolizing bacteria of the Bilophila genus, which expand in response to dietary fat intake, were recently identified as pathobionts, capable of promoting colitis 99,100 .…”
Section: Discussionmentioning
confidence: 99%
“…We also show an association between ST6GAL1 expression and reduced colonization of Helicobacter and Bilophila species, which are collectively implicated in the pathogenesis of infection, cancer, and metabolic dysfunction [98][99][100] . Interestingly, free sialic acid has been shown to have anti-Helicobacter properties both in vitro and in vivo [101][102][103][104][105][106] . Bile-metabolizing bacteria of the Bilophila genus, which expand in response to dietary fat intake, were recently identified as pathobionts, capable of promoting colitis 99,100 .…”
Section: Discussionmentioning
confidence: 99%
“…A greater abundance of Helicobacter in ST6GAL1-deficient animals is consistent with a number of previous reports demonstrating anti-Helicobacter activity of soluble sialic acid preparations by at least two independent mechanisms. Firstly, sialic acid has direct antibacterial properties towards Helicobacter species both in vitro and in vivo, an effect that is augmented by co-administration of antioxidant catechins [103][104][105][106] . Secondly, sialylated gastrointestinal mucins, particularly those of the stomach, act as decoys for Helicobacter strains expressing the sialic acid binding SabA adhesin by competing with sialylated structures in the gastric epithelial surface necessary for initiating infection [135][136][137][138] .…”
Section: Discussionmentioning
confidence: 99%